These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3723240)

  • 21. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
    Simpson IN; Finlay J; Winstanley DJ; Dewhurst N; Nelson JW; Butler SL; Govan JR
    J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment.
    Mortensen JE; Fisher MC; LiPuma JJ
    Infect Control Hosp Epidemiol; 1995 Jan; 16(1):30-2. PubMed ID: 7534780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.
    Carson LA; Tablan OC; Cusick LB; Jarvis WR; Favero MS; Bland LA
    J Clin Microbiol; 1988 Oct; 26(10):2096-100. PubMed ID: 3182996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.
    Lewin LO; Byard PJ; Davis PB
    J Clin Epidemiol; 1990; 43(2):125-31. PubMed ID: 2303842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.
    Pitchford KC; Corey M; Highsmith AK; Perlman R; Bannatyne R; Gold R; Levison H; Ford-Jones EL
    J Pediatr; 1987 Aug; 111(2):212-6. PubMed ID: 3612391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
    Aronoff SC; Klinger JD
    J Antimicrob Chemother; 1985 May; 15(5):545-9. PubMed ID: 3924879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.
    Welch DF; Muszynski MJ; Pai CH; Marcon MJ; Hribar MM; Gilligan PH; Matsen JM; Ahlin PA; Hilman BC; Chartrand SA
    J Clin Microbiol; 1987 Sep; 25(9):1730-4. PubMed ID: 3654943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.
    Christenson JC; Welch DF; Mukwaya G; Muszynski MJ; Weaver RE; Brenner DJ
    J Clin Microbiol; 1989 Feb; 27(2):270-3. PubMed ID: 2915020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.
    Klinger JD; Aronoff SC
    J Antimicrob Chemother; 1985 Jun; 15(6):679-84. PubMed ID: 3161856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
    da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
    Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of selective medium for Burkholderia cepacia isolation in respiratory samples from cystic fibrosis patients.
    da Silva Filho LV; Velloso Lde F; Bento CN; Gytin E; Tateno AF; Levi JE; Rodrigues JC; Ramos SR
    Rev Inst Med Trop Sao Paulo; 2002; 44(4):203-8. PubMed ID: 12219111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern.
    Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S
    Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.
    Cimolai N; Trombley C; Davidson AG; Wong LT
    J Clin Pathol; 1995 May; 48(5):488-90. PubMed ID: 7543119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.
    Chiesa C; Labrozzi PH; Aronoff SC
    Pediatr Res; 1986 Nov; 20(11):1174-7. PubMed ID: 3540826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of Burkholderia cepacia by enrichment.
    Flanagan PG; Paull A
    J Clin Pathol; 1998 Jul; 51(7):557-8. PubMed ID: 9797739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.
    Muhdi K; Edenborough FP; Gumery L; O'Hickey S; Smith EG; Smith DL; Stableforth DE
    Thorax; 1996 Apr; 51(4):374-7. PubMed ID: 8733488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.
    Thomassen MJ; Klinger JD; Badger SJ; van Heeckeren DW; Stern RC
    J Pediatr; 1984 Mar; 104(3):352-6. PubMed ID: 6423790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.